(

a) The department shall notify each manufacturer of drugs in therapeutic categories selected pursuant to

Section 14105.33 of the provisions of Sections 14105.31 to 14105.42, inclusive. (

b) If, within days of notification, a manufacturer does not enter into negotiations for a contract pursuant to those sections, the department may suspend or delete from the list of contract drugs, or refuse to consider for addition, drugs of that manufacturer in the selected therapeutic categories. (

c) If, after days from the initial notification, a contract is not executed for a drug currently on the list of contract drugs, the department may suspend or delete the drug from the list of contract drugs. (

d) If, within days from the initial notification, a contract is executed for a drug currently on the list of contract drugs, the department shall retain the drug on the list of contract drugs. (

e) If, within days from the date of the initial notification, a contract is executed for a drug not currently on the list of contract drugs, the department shall add the drug to the list of contract drugs. (

f) The department shall terminate all negotiations days after the initial notification. (

g) The department may suspend or delete any drug from the list of contract drugs at the expiration of the contract term or when the contract between the department and the manufacturer of that drug is terminated. (

h) In the absence of a contract, the department may suspend or delete any drug from the list of contract drugs. (

i) Any drug suspended from the list of contract drugs pursuant to this

section or

Section 14105.35 shall be subject to prior authorization, as if that drug were not on the list of contract drugs. (

j) Any drug suspended from the list of contract drugs pursuant to this

section or

Section 14105.35 may be deleted from the list of contract drugs in accordance with

Section 14105.38.